| No. |
Date |
Time |
Seminar Title |
Register |
| Keynote / Special Seminar |
| Keynote Seminar |
| 6K-12 |
19 April (Fri.) |
09:30
|
10:30 |
Amplifying Impact and Delivering Lasting Value for Patient
Mr. James C. Feliciano
President
AbbVie Japan
|
|
| Special Guest Seminar |
| 6K-08 |
18 April (Thu.) |
11:30
|
12:30 |
Takeda R&D Strategic Transformation: Reflections, Successes and Learnings
Mr. Andrew S. Plump
President
Research & Development
Takeda Pharmaceutical Company Limited
|
|
| Special Seminar |
| 6K-05 |
17 April (Wed.) |
15:00
|
16:00 |
Annual Pharma R&D Review: How did the global pipeline develop in 2023?
Mr. Ian Haydock
Editor-in-Chief, APAC
Insights
Citeline
|
|
| 6K-09 |
18 April (Thu.) |
14:00
|
16:00 |
＜JPTA Conference＞
Recent Situations and Challenges in Stable Supply of Active Pharmaceutical Ingredients
Opening remarks by Mr. Ichiro Fujikawa, Chairperson of JAPTA
1. China
Ms. Cynthia Ban, VP, CCCMHPIE（President of Zhejiang Langhua）
2. India
Dr. Rajeev Rehani Budhdev, Executive Vice President & Head– API R&D and Delivery at Dr. Reddy’s Laboratories Limited.
3. Europe
Ms. Marieke van Daren, former board member, representing APIC
Closing remarks by Mr. Hiroshi Nakamura, JAPTA
|
|
| 6K-16 |
19 April (Fri.) |
15:40
|
16:30 |
The current situation and measures regarding the stable supply of pharmaceuticals
Mr. Go Yamamoto
Director, Venture Support Strategy Office
Policy Planning Division for Pharmaceutical Industry Promotion and Medical Information Management, Health Policy Bureau
Ministry of Health, Labour and Welfare
|
|
| Conference |
| Conference【4C】 |
| 4C-02 |
17 April (Wed.) |
11:45
|
12:45 |
Putting ESG into Practice - Creating Responsible Supply Chains using Common Audit Approaches
Ms. Caroline O’Brien,
Global Quality Audit - Hub Director Asia Pacific,
AstraZeneca & former PSCI chair
|
|
| CDMO Conference |
| 5A-08 |
18 April (Thu.) |
11:30
|
12:15 |
From Monoclonal antibody to ADC, transforming innovative concepts into reality.
Mr. Kern Chang
Chief Technical Officer
Technical Development
LOTTE BIOLOGICS
|
|
| Drug Formulation Development Seminar |
| 4C-06 |
18 April (Thu.) |
10:30
|
11:30 |
Regulatory Considerations in Drug Formulation
Azedine Barik, PhD
CEO & Principal Consultant
CMC & Regulatory Affairs
PMP Consulting Co., Ltd.
|
|
| India Seminar |
| AR-02 |
17 April (Wed.) |
13:30
|
15:00 |
【3/28 Updated】
Enduring Partnership for Healthcare & Pharmaceuticals – “India & Japan”
Dr. Gurpreet Sandhu
President
Council for Healthcare & Pharma, India
Mr. Makoto Matsukawa
Representative Director & CEO
CMIC CMO, Japan
Please note that this seminar will be held in Ariake Central Tower Hall&Conference 4F. (5-min walk from Tokyo Big Sight)
|
|
| Pharma IT Seminar |
| Pharma IT Seminar【4B】 |
| 4B-02 |
17 April (Wed.) |
11:40
|
12:40 |
Technology Driving Change and Opportunity in Japan Pharmaceutical Market – from Clinical to Manufacturing to Commercialization.
IQVIA Solutions Japan G.K.
Strategy & Corporate Development
Sr Dir, Strategic Planning
Mr. Alan Thomas
|
|
|
| TFT-01 |
19 April (Fri.) |
15:00
|
17:00 |
|
|
